In this issue:
Psoriasis flares following systemic glucocorticoid exposure
Incidence and prevalence of psoriasis by age and gender
EuroGuiDerm guidelines on systemic psoriasis vulgaris treatment
Real-world analysis of patients receiving treatment for psoriasis
Patient impact and commonly used clinical psoriasis thresholds
Definition of minimal disease activity
Treat-to-target of moderate-to-severe plaque psoriasis
Dermatologists’ perspectives on defining moderate psoriasis
Neonatal and maternal outcomes with psoriasis vulgaris
Cyclosporine vs methotrexate vs acitretin for palmoplantar psoriasis
Impact of COVID-19 in patients with psoriasis
Please login below to download this issue (PDF)